Things have moved faster than normal, but we have done everything correctly. The FDA was able to approve an Emergency Use Authorization for Pfizer based on its good safety and efficacy profile. We have been very careful in monitoring safety and have taken no short cuts in evaluating the vaccines at Cincinnati Children’s. Almost 40,000 people enrolled in Pfizer nationwide, over 30,000 enrolled in Moderna and close to 30,000 for both Janssen and AstraZeneca. Thus, we will have a lot of safety data before the other vaccines are licensed.